Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) Financials
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 3, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the DHCNL SEC filings page.
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) reported $1.5B in revenue over the twelve months to Jun 30, 2026, down 1.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Balance-sheet reshaping and debt reduction are visible as operating results remain unable to produce dependable cash.
FY2025 net income improved to-$285.9M , yet operating cash flow turned negative after being positive in FY2024; earnings improvement did not translate into cash. The$483.6M investing inflow nearly offset the$492.0M financing outflow, indicating that balance-sheet activity, not recurring operations, drove the major cash movements.
Revenue reached
Debt fell from
Financial Health Signals
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 passes 4 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 reported a net loss of $285.9M while operations used $19.6M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 generated $365.4M in revenue in Q2 2026. This represents a decrease of 4.5% from the same quarter a year earlier. Against the prior quarter it is down 0.3%.
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 reported -$37.4M in net income in Q2 2026. This represents an increase of 59.2% from the same quarter a year earlier. Against the prior quarter it is up 13.5%.
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 earned -$0.16 per diluted share (EPS) in Q2 2026. This represents an increase of 57.9% from the same quarter a year earlier. Against the prior quarter it is up 11.1%.
Not reported for Q2 2026.
Cash & Balance Sheet
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 held $116.8M in cash against $2.4B in long-term debt as of Q2 2026.
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 paid $0.01 per share in dividends in Q2 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.
Not reported for Q2 2026.
Margins & Returns
Diversified Healthcare Trust 6.25% Senior Notes Due 2046's net profit margin was -10.2% in Q2 2026, showing the share of revenue converted to profit. This is up 13.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.6 percentage points.
Diversified Healthcare Trust 6.25% Senior Notes Due 2046's ROE was -2.4% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 2.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.3 percentage points.
Not reported for Q2 2026.
Not reported for Q2 2026.
Capital Allocation
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 spent $50K on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 51.5% from the same quarter a year earlier. Against the prior quarter it is down 43.2%.
Not reported for Q2 2026.
Not reported for Q2 2026.
DHCNL Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $365.4M-4.5% | $366.5M-5.3% | $379.6M0.0% | $388.7M+4.0% | $382.7M+3.0% | $386.9M+4.3% | $379.6M+5.0% | $373.6M+4.8% |
| SG&A Expenses | $19.3M+73.0% | $14.0M+56.0% | $12.5M+1106.9% | $12.8M-8.2% | $11.2M+78.5% | $9.0M+18.9% | -$1.2M-120.7% | $13.9M+100.4% |
| Interest Expense | $37.1M-27.2% | $37.0M-35.9% | $46.9M-21.3% | $48.9M-17.8% | $50.9M-13.2% | $57.8M+0.4% | $59.5M+21.8% | $59.4M+24.5% |
| Income Tax | $1.3M+53.9% | $622K+1169.4% | $514K+1452.6% | $337K+127.7% | $843K+395.9% | $49K-73.8% | -$38K-157.6% | $148K-21.7% |
| Net Income | -$37.4M+59.2% | -$43.3M-381.6% | -$21.2M+75.7% | -$164.0M-66.2% | -$91.6M+6.4% | -$9.0M+89.6% | -$87.4M+14.7% | -$98.7M-50.0% |
| EPS (Basic) | -$0.16+57.9% | -$0.18-350.0% | -$0.09+75.7% | -$0.68-65.9% | -$0.38+7.3% | -$0.04+88.9% | -$0.37+14.0% | -$0.41-46.4% |
| EPS (Diluted) | -$0.16+57.9% | -$0.18-350.0% | -$0.09+75.7% | -$0.68-65.9% | -$0.38+7.3% | -$0.04+88.9% | -$0.37+14.0% | -$0.41-46.4% |
| Diluted Shares (Avg) | 241M+0.3% | 241M+0.3% | N/A | 240M+0.3% | 240M+0.3% | 240M+0.3% | N/A | 240M+0.3% |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA.
DHCNL Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $4.2B-10.9% | $4.3B-14.6% | $4.4B-15.1% | $4.7B-11.4% | $4.8B-10.8% | $5.0B-6.6% | $5.1B-5.7% | $5.3B-4.4% |
| Cash & Equivalents | $116.8M-17.6% | $121.8M-59.8% | $105.4M-27.1% | $201.4M-21.5% | $141.8M-46.6% | $302.6M+46.1% | $144.6M-41.2% | $256.5M-7.8% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $2.7B-8.5% | $2.6B-13.1% | $2.7B-15.2% | $3.0B-7.5% | $2.9B-8.9% | $3.0B-1.7% | $3.2B+2.2% | $3.2B+4.8% |
| Long-Term Debt | $2.4B | $2.4B | $2.4B-19.9% | N/A | N/A | N/A | $3.1B | N/A |
| Total Equity | $1.6B-14.7% | $1.6B-16.8% | $1.7B-15.0% | $1.7B-17.6% | $1.9B-13.7% | $1.9B-13.4% | $2.0B-16.2% | $2.0B-16.1% |
| Retained Earnings | $1.0B-20.3% | $1.1B-22.9% | $1.1B-20.3% | $1.1B-23.5% | $1.3B-18.0% | $1.4B-17.3% | $1.4B-20.8% | $1.5B-20.5% |
Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Goodwill, Current Liabilities, Non-Current Liabilities.
DHCNL Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $38.4M-27.6% | $8.3M+357.2% | -$20.1M-210.5% | -$49.3M-333.2% | $53.0M+19.7% | -$3.2M-111.3% | $18.2M+352.4% | $21.1M+250.6% |
| Depreciation & Amortization | $62.5M-5.6% | $62.9M-7.9% | $62.0M-20.0% | $65.3M-5.3% | $66.3M-3.1% | $68.3M-2.6% | $77.5M-7.3% | $69.0M+2.6% |
| Investing Cash Flow | -$38.7M-84.0% | $13.6M-95.3% | $207.4M+413.6% | $6.1M+124.3% | -$21.1M+42.9% | $291.1M+594.7% | -$66.1M-29.0% | -$25.2M+58.3% |
| Financing Cash Flow | -$3.3M+98.3% | -$3.9M+97.0% | -$275.1M-332.6% | $104.2M+2351.8% | -$190.0M-448.8% | -$131.0M-1430.8% | -$63.6M-341.6% | -$4.6M-33.0% |
| Dividends Paid | $2.4M+0.3% | $2.4M+0.3% | $2.4M+0.3% | $2.4M+0.3% | $2.4M+0.4% | $2.4M+0.4% | $2.4M+0.4% | $2.4M+0.3% |
| Share Buybacks | $50K-51.5% | $88K+1366.7% | $82K+4000.0% | $954K+22.2% | $103K+139.5% | $6K-92.3% | $2K-71.4% | $781K+121.2% |
Not reported in any period shown, so not listed: Stock-Based Compensation, Capital Expenditures, Free Cash Flow.
DHCNL Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Net Margin | -10.2%+13.7pp | -11.8%-9.5pp | -5.6%+17.4pp | -42.2%-15.8pp | -23.9%+2.4pp | -2.3%+20.9pp | -23.0%+5.3pp | -26.4%-8.0pp |
| Return on Equity | -2.4%+2.6pp | -2.7%-2.2pp | -1.3%+3.2pp | -9.7%-4.9pp | -4.9%-0.4pp | -0.5%+3.4pp | -4.5%-0.1pp | -4.8%-2.1pp |
| Return on Assets | -0.9%+1.1pp | -1.0%-0.8pp | -0.5%+1.2pp | -3.5%-1.6pp | -1.9%-0.1pp | -0.2%+1.4pp | -1.7%+0.2pp | -1.9%-0.7pp |
| Debt-to-Equity | 1.540.0x | 1.51-0.1x | 1.47-0.1x | 1.77+0.2x | 1.56+0.1x | 1.56+0.2x | 1.56+0.2x | 1.58+0.3x |
| Asset Turnover | 0.090.0x | 0.090.0x | 0.090.0x | 0.080.0x | 0.080.0x | 0.080.0x | 0.070.0x | 0.070.0x |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, FCF Margin.
Where Diversified Healthcare Trust 6.25% Senior Notes Due 2046 Ranks
Frequently Asked Questions
What is Diversified Healthcare Trust 6.25% Senior Notes Due 2046's annual revenue?
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) reported $1.5B in total revenue for fiscal year 2025. This represents a 2.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Diversified Healthcare Trust 6.25% Senior Notes Due 2046's revenue growing?
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) revenue grew by 2.8% year-over-year, from $1.5B to $1.5B in fiscal year 2025.
Is Diversified Healthcare Trust 6.25% Senior Notes Due 2046 profitable?
No, Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) reported a net income of -$285.9M in fiscal year 2025, with a net profit margin of -18.6%.
How much debt does Diversified Healthcare Trust 6.25% Senior Notes Due 2046 have?
As of fiscal year 2025, Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) had $105.4M in cash and equivalents against $2.4B in long-term debt.
What is Diversified Healthcare Trust 6.25% Senior Notes Due 2046's net profit margin?
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) had a net profit margin of -18.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does Diversified Healthcare Trust 6.25% Senior Notes Due 2046 pay dividends?
Yes, Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) paid $0.04 per share in dividends during fiscal year 2025.
What is Diversified Healthcare Trust 6.25% Senior Notes Due 2046's return on equity (ROE)?
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) has a return on equity of -17.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Diversified Healthcare Trust 6.25% Senior Notes Due 2046's operating cash flow?
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) recorded an outflow of $19.6M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Diversified Healthcare Trust 6.25% Senior Notes Due 2046's total assets?
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) had $4.4B in total assets as of fiscal year 2025, including both current and long-term assets.
What is Diversified Healthcare Trust 6.25% Senior Notes Due 2046's debt-to-equity ratio?
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) had a debt-to-equity ratio of 1.47 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Diversified Healthcare Trust 6.25% Senior Notes Due 2046's return on assets (ROA)?
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) had a return on assets of -6.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
How does Diversified Healthcare Trust 6.25% Senior Notes Due 2046's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) held $105.4M in cash, cash equivalents and investments, and reported an operating cash outflow of $19.6M over that year. Dividing the one by the other, the reported balance equals about 64 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is Diversified Healthcare Trust 6.25% Senior Notes Due 2046's Piotroski F-Score?
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) has a Piotroski F-Score of 4 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Diversified Healthcare Trust 6.25% Senior Notes Due 2046's earnings high quality?
Diversified Healthcare Trust 6.25% Senior Notes Due 2046 (DHCNL) reported a net loss of $285.9M while operations used $19.6M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.